High Vista Strategies LLC Dice Therapeutics, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $1.18 Million - $2.14 Million	-45,800 Reduced 68.0%	21,557 $1 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $737,032 - $914,146	28,293 Added 72.43%	67,357 $1.93 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $772,295 - $1.65 Million	39,064 New	39,064 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $645,782 - $1.08 Million	-48,960 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $711,878 - $1.22 Million	48,960 New	48,960 $937,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.